• This is a political forum that is non-biased/non-partisan and treats every person's position on topics equally. This debate forum is not aligned to any political party. In today's politics, many ideas are split between and even within all the political parties. Often we find ourselves agreeing on one platform but some topics break our mold. We are here to discuss them in a civil political debate. If this is your first visit to our political forums, be sure to check out the RULES. Registering for debate politics is necessary before posting. Register today to participate - it's free!

Shortages Lead Doctors To Ration Critical Drugs

ludahai

Defender of the Faith
DP Veteran
Joined
Apr 24, 2005
Messages
10,320
Reaction score
2,116
Location
Taichung, Taiwan - 2017 East Asian Games Candidate
Gender
Male
Political Leaning
Very Conservative
article

Drug shortages mean a growing number of Americans aren't getting the medications they need. That's causing drug companies and doctors to ration available medications in some cases.

"We're now at 213 shortages for this year," says Erin Fox of the University of Utah, who tracks national drug shortages. "That surpasses last year's total of 211. And it doesn't seem like there's an end in sight."

The shortages involve a wide range of medications: cancer chemotherapy agents, anesthetics, antibiotics, electrolytes needed for nutrient solutions, and dozens more. One drug currently in short supply is used in critically ill patients to bring down soaring blood pressure.

This is unbelievable. There is no excuse for having this situation in the United States. The profit motive is essential to ensure there are enough drugs. Take that away, and the companies have no incentive to produce the drugs. Of course, detractors would note that this is what is wrong with the profit-driven system.

Comments? Observations?
 
article



This is unbelievable. There is no excuse for having this situation in the United States. The profit motive is essential to ensure there are enough drugs. Take that away, and the companies have no incentive to produce the drugs. Of course, detractors would note that this is what is wrong with the profit-driven system.

Comments? Observations?

Um. Are you suggesting these shortages are a result of a lack of profit motive? I'm not sure I'm understanding your post.
 
article



This is unbelievable. There is no excuse for having this situation in the United States. The profit motive is essential to ensure there are enough drugs. Take that away, and the companies have no incentive to produce the drugs. Of course, detractors would note that this is what is wrong with the profit-driven system.

Comments? Observations?
i can't agree with your conclusions. read this excerpt from the cited article:
... But actually, officials at the Food and Drug Administration say only 11 percent of shortages happen because a company decides to stop making an unprofitable drug. Most shortages, they say, occur because something goes wrong in the manufacturing process that halts production.

The problem today is there are fewer companies making essential drugs. So when one manufacturer stops producing, there may be only one other supplier – and it can't keep up with demand. ...
that 11% will provide an opportunity for some supplier
because the shortage will force the price of these generic drugs to increase to the point it will become profitable for a manufacturer to once again fabricate the medical concoctions
the invisible hand will work

as for the other 89% due to manufacturing snafus and the absence of alternative sources, the article tells us little. are there no alternative vendors because of the proprietary claims of the present manufacturers? if so, we have two choices, eliminate the proprietary rights and go generic ... to join that other 11% described above, or tolerate flawed product when the manufacturing snafus occur. neither seems a good option
 
i can't agree with your conclusions. read this excerpt from the cited article:
that 11% will provide an opportunity for some supplier
because the shortage will force the price of these generic drugs to increase to the point it will become profitable for a manufacturer to once again fabricate the medical concoctions
the invisible hand will work

as for the other 89% due to manufacturing snafus and the absence of alternative sources, the article tells us little. are there no alternative vendors because of the proprietary claims of the present manufacturers? if so, we have two choices, eliminate the proprietary rights and go generic ... to join that other 11% described above, or tolerate flawed product when the manufacturing snafus occur. neither seems a good option

Alot of the drugs I expect also have a limited shelf life making manufacturing issues even more of an issue
 
article



This is unbelievable. There is no excuse for having this situation in the United States. The profit motive is essential to ensure there are enough drugs. Take that away, and the companies have no incentive to produce the drugs. Of course, detractors would note that this is what is wrong with the profit-driven system.

Comments? Observations?

there's plenty of profit motive.

perhaps if a company can't or won't meet demand for an essential drug, it should significantly shorten their patent on it. plenty of generic companies are ready to crank these medicines out by the ton, and at a moment's notice.
 
The US has a closed system so when the protected pharmaceutical manufacturers can't meet demand it is the citizens of the US who suffer. There is virtually no reason for manufacturers to spend the money to make sure manufacturing does not break down because they don't have to worry that their competition will fill in the gap while they are down. If we had a free market economy in play, things would be done much differently.
 
This is unbelievable. There is no excuse for having this situation in the United States. The profit motive is essential to ensure there are enough drugs. Take that away, and the companies have no incentive to produce the drugs. Of course, detractors would note that this is what is wrong with the profit-driven system.

What are you rambling about? The pharmaceutical industry is very well protected by government favoritism and earns a nice big fat profit because of it. In 2009, they were the third leading industry in regards to profit margin, earning average profit of 19.3 cents per dollar of sales
Fortune 500 2009: Top Performers - Most Profitable Industries: Return on Revenues

As of this year, major drug manufacturers earn an average of 16.7 cents per dollar of sales.
Industry Browser - Yahoo! Finance - Full Industry List
 
Not a shock at all... happens when you live in a monopolistic system like the US.
 
I have 3 Stints in my heart requiring that I take blood thinner and Plavix every day for the rest of my life and there is no Generic I can buy, and the pills cost $200 at Walmart so I don't want to hear how the profit margins are two small.

If they a medication that doesn't leave then with a big profit, they make it up with outrages profits on another one.

I figure Plavix real cost is most likely about $0.25 per pill if that. I sure hope the Congress passes some kind Law to stop this BS.
 
We should import medications from Canada.
 
We should import medications from Canada.
This would certainly help bend the cost curve down.
I have 3 Stints in my heart requiring that I take blood thinner and Plavix every day for the rest of my life and there is no Generic I can buy, and the pills cost $200 at Walmart so I don't want to hear how the profit margins are two small.
I just checked the price of a month's supply of Plavix (75mg) from three Canadian on-line pharmacies - $76, $71 and $79. If the US allowed you to buy this from Canada, the cost would drop dramatically as free market competition would regulate the prices.

I've never understood why the GOP almost universally and a majority of the Dems have so fiercely protected Big Pharm from the free market. They do the same thing with durable medical equipment and routine medical supplies like catheters, stoma supplies, diabetes testing, wounds care supplies, compression hoses and such.

Breaking this monopoly was one of the things ObamaCare planned to address - and it is why Big Pharm and Big Med Supply poured so much money into electing Congressmen who would not allow any part of the monopoly-busting to pass.
 
I just checked the price of a month's supply of Plavix (75mg) from three Canadian on-line pharmacies - $76, $71 and $79. If the US allowed you to buy this from Canada, the cost would drop dramatically as free market competition would regulate the prices.

Would help yes, but hardly a free market since there are even certain restrictions in Canada.

I've never understood why the GOP almost universally and a majority of the Dems have so fiercely protected Big Pharm from the free market. They do the same thing with durable medical equipment and routine medical supplies like catheters, stoma supplies, diabetes testing, wounds care supplies, compression hoses and such.

Money.. Big pharma is one of the biggest political backers out there. But they of course use excuses of dangerous Mexican and Cuban drugs flooding into the US or Nigerian fake drugs. A valid argument, but that does not justify banning drugs from Europe or Canada...

Breaking this monopoly was one of the things ObamaCare planned to address - and it is why Big Pharm and Big Med Supply poured so much money into electing Congressmen who would not allow any part of the monopoly-busting to pass.

Big pharma is powerful world wide. The EU has for decades tried to break their strangle hold on Europe and have so far lost. It was last year or so that the court system found in favour of the drug industry to keep in place restrictions on cross border drug selling. Their argument was safety of course... one of the only arguments allowed per the treaty to keep competition harming rules in place.

Thankfully while our politicians are some what complicit in keeping the status quo on the restrictions, they at the same time have put in place various rules and regulations that put big pressure on the drug companies to keep prices realistic. This varies from country to country, but it works... only problem not all countries have such regulations and one of the biggest fears of the drug companies of an open market for pharma was that people would flood to low priced areas of Europe (good regulation) and buy drugs to sell in high price areas (lax regulation)..... and that was exactly what the EU wanted so to lower prices even more. Sadly the EU lost for now. As an example of regulation.. in Spain it is now mandatory for doctors to proscribe generic brands over named brands if the medicine and effect are the same. This will save the Spanish healthcare system billions a year.

But no where is the power of big pharma as big as in Switzerland. Having the second most expensive healthcare system in the world after the US, and 100% private, the Swiss have for years been seriously discussing dumping the private system and putting in place a public/private system instead. But big pharma uses huge amounts of money to combat politicians and organisations who float the idea and hence making any realistic debate about it, fall apart almost before it starts. One of their lame arguments is the amount of jobs Switzerland will loose.... and ironically the money used for these campaigns come from gauging the population on private care and insurance..

And before people come and claim the usual big pharma argument for these anti-competitive actions..the "we need the money to do R&D" argument.. bull****... big pharma uses more on marketing and advertising that it uses on R&D.
 
I just checked the price of a month's supply of Plavix (75mg) from three Canadian on-line pharmacies - $76, $71 and $79. If the US allowed you to buy this from Canada, the cost would drop dramatically as free market competition would regulate the prices.

I've never understood why the GOP almost universally and a majority of the Dems have so fiercely protected Big Pharm from the free market. They do the same thing with durable medical equipment and routine medical supplies like catheters, stoma supplies, diabetes testing, wounds care supplies, compression hoses and such.

Breaking this monopoly was one of the things ObamaCare planned to address - and it is why Big Pharm and Big Med Supply poured so much money into electing Congressmen who would not allow any part of the monopoly-busting to pass.

Well, as sig says, America believes in corporate socialism and public capitalism.
 
I have 3 Stints in my heart requiring that I take blood thinner and Plavix every day for the rest of my life and there is no Generic I can buy, and the pills cost $200 at Walmart so I don't want to hear how the profit margins are two small.

because of our poor system of tying health insurance to employment, the copay for an essential medicine i take is now $200 a month because i had to change jobs. it was $30 per month at my previous job. no generic, no alternative available.

this system is unsustainable.
 
because of our poor system of tying health insurance to employment, the copay for an essential medicine i take is now $200 a month because i had to change jobs. it was $30 per month at my previous job. no generic, no alternative available.

this system is unsustainable.

what do you propose as the solution?
 
there's plenty of profit motive.

perhaps if a company can't or won't meet demand for an essential drug, it should significantly shorten their patent on it. plenty of generic companies are ready to crank these medicines out by the ton, and at a moment's notice.

Actually, there is not nearly as much profit in generics as there is in drugs where the patent is still owned. So perhaps part of the solution would be to LENGTHEN patents...
 
what do you propose as the solution?

health care should not be tied to employment. an employer could provide funds for the purchase of health insurance, and the employee would buy the policy on an exchange. also on this exchange will be a competitively priced option to buy into medicare early, which is needed to place downward pressure on skyrocketing private plans.

the cost problem needs to be addressed. we need more doctors, and we need to make it simpler and more economical for students to go to medical school.

finally, we need to remove some excuses that the pharmaceutical companies have for charging outlandish amounts of money for medications. first, it shouldn't cost a billion dollars to bring a drug to market. i'm not entirely convinced aspirin would reach the market if it were developed today. the consumer is going to have to accept that there is some degree of risk with any medication. this doesn't mean releasing prescription pharmaceuticals into the market untested, but there is certainly some middle ground that we could explore.

if that's not enough to bring costs down, then there are other a few other nuclear options we could try. we could develop some pharmaceuticals publicly, funding direct research and development as we currently fund basic research through the grant system. we wouldn't have to do much of that to give pharmaceutical companies additional competition. the manufacture of publicly developed medicines could be sold to private industry, or that could be public, as well. perhaps we should consider re-examining patents as well. the novel nature of any medicine would play a role, as would the proposed pricing structure.

and if none of the above works, we move to single payer public health insurance and force the prices down.

our current system is rising in cost at an unsustainable rate. something is going to have to be done.
 
health care should not be tied to employment.
i don't disagree with this. it's a holdover from after WWII when compensation was arbitrarily held down. health care via the employer was added as an available incentive not restricted by the compensation limits

an employer could provide funds for the purchase of health insurance,
for the wage earner, isn't this the source of funds for almost all of the employee's purchases? why treat health insurance any differently that any other commodity?

and the employee would buy the policy on an exchange.
isn't this part of the Obama plan?

also on this exchange will be a competitively priced option to buy into medicare early, which is needed to place downward pressure on skyrocketing private plans.
why would such effect be the expected outcome?

the cost problem needs to be addressed. we need more doctors, and we need to make it simpler and more economical for students to go to medical school.
could not agree more. would suggest that we have medical academies like military academies where the students would leave with credentials and a multi-year obligation to serve the public
by expanding the supply of medical practitioners, we would diminish the demand on each
there are many today who are qualified to go to medical school but are without the means to do so. such a waste of talent. talent our nation desperately needs

finally, we need to remove some excuses that the pharmaceutical companies have for charging outlandish amounts of money for medications. first, it shouldn't cost a billion dollars to bring a drug to market.
why? a cure for cancer or a cure for aids for $1 billion. that would be a bargain in my opinion

i'm not entirely convinced aspirin would reach the market if it were developed today. the consumer is going to have to accept that there is some degree of risk with any medication.
we already do. listen to the disclaimers being spoken on the tv ads for new drugs. it amazes me that people even take them knowing the potential dire consequences

this doesn't mean releasing prescription pharmaceuticals into the market untested, but there is certainly some middle ground that we could explore.
seems to me like you are seeking the drugs be made available faster at the expense of some problems not being found
i was a member of the thalidomide generation. my Mom actually took it for morning sickness while carrying me. fortunately, i was not one of the (directly) afflicted but here is a cite to see images of that tragic outcome. one which resulted because we allowed that drug to proceed to market too fast (warning, these images may be shocking):
thalidomide babies - Google Search


if that's not enough to bring costs down, then there are other a few other nuclear options we could try. we could develop some pharmaceuticals publicly, funding direct research and development as we currently fund basic research through the grant system.
we already do this. it's one good reason why the research triangle is one of the leading biotech centers in the world. we coordinated federal and state funds to advance such research

we wouldn't have to do much of that to give pharmaceutical companies additional competition. the manufacture of publicly developed medicines could be sold to private industry, or that could be public, as well. perhaps we should consider re-examining patents as well.
if they must relinquish the unique ability to manufacture and profit from what they have developed then what incentive will the pharm company have to engage in private research

the novel nature of any medicine would play a role, as would the proposed pricing structure.
is it other than supply and demand? if so, what alternate pricing mechanism is being employed

and if none of the above works, we move to single payer public health insurance and force the prices down.
how does single payer coverage cause cost/price to come down?

our current system is rising in cost at an unsustainable rate. something is going to have to be done.

on this we agree. trouble is, there seem to be few realistic ways to address this growing problem
 
justabubba said:
for the wage earner, isn't this the source of funds for almost all of the employee's purchases? why treat health insurance any differently that any other commodity?

i would make it a separate compensation package to prevent employers form eliminating it entirely or absorbing it into an already depressed wage.


justabubba said:
isn't this part of the Obama plan?

there are some good parts to the plan, but under his plan, many will still be tied to employer-specific coverage.


justabubba said:
why would such effect be the expected outcome?

because medicare doesn't have to produce large profits and attract shareholders. having it in competition will force health insurance providers to bring down premiums as much as possible. the pricing of the medicare buy in can be adjusted to be competitive with other plans, or it can be made available to those who fall below a certain income threshold.

justabubba said:
why? a cure for cancer or a cure for aids for $1 billion. that would be a bargain in my opinion

and it would bankrupt nearly everyone who underwent the treatment, making it only available to the super-rich.

if a company wants to charge an outlandish price for a groundbreaking drug, that should affect the length of their patent.

justabubba said:
seems to me like you are seeking the drugs be made available faster at the expense of some problems not being found
i was a member of the thalidomide generation. my Mom actually took it for morning sickness while carrying me. fortunately, i was not one of the (directly) afflicted but here is a cite to see images of that tragic outcome. one which resulted because we allowed that drug to proceed to market too fast

my mother took a pill decades ago during pregnancy. in the 1980s, it was found to cause respiratory defects. i was born with emphysema in one of my lungs, and had to have an upper lobe removed at two weeks of age. the defect was likely due to the medication. the company was sued, but my parents thought participating would be an exercise in futility.

however, this momentary lapse into anecdotal evidence is irrelevant to the point, other than to prove that i have skin in the game, so to speak. something has to be done to reduce the cost of bringing a drug to market if we are to bring the cost of the medication down. i don't see a way of doing that without having the consumer accept a degree of risk, much as they are doing now.


justabubba said:
if they must relinquish the unique ability to manufacture and profit from what they have developed then what incentive will the pharm company have to engage in private research

i was referring to the manufacture of drugs developed publicly. a publicly developed drug could be manufactured publicly or privately.


justabubba said:
is it other than supply and demand? if so, what alternate pricing mechanism is being employed

demand for these products is inelastic. while the company should profit from the discovery, it should not be permitted to hold the drug hostage and demand a ransom that would cause widespread increases in the cost of access to healthcare. the system as it is set up is imploding from the bottom up.

if your argument is that no private company will develop life saving drugs if they are not allowed to charge ridiculously high prices for them, i disagree. and if you're right, we can address the need by developing pharmaceuticals publicly.


justabubba said:
how does single payer coverage cause cost/price to come down?

because single payer would mean one large group that would only pay a certain amount for medical services. this would put a downward force on overall prices.

justabubba said:
on this we agree. trouble is, there seem to be few realistic ways to address this growing problem

agree. the chance of my own solution being seriously entertained is minimal at this point; it may become more likely after a systemic collapse, however. but since we are speaking of solutions, it can't hurt to consider solutions whose time has not yet come.
 
I have 3 Stints in my heart requiring that I take blood thinner and Plavix every day for the rest of my life and there is no Generic I can buy, and the pills cost $200 at Walmart so I don't want to hear how the profit margins are two small.

If they a medication that doesn't leave then with a big profit, they make it up with outrages profits on another one.

I figure Plavix real cost is most likely about $0.25 per pill if that. I sure hope the Congress passes some kind Law to stop this BS.

"Small government. Except when companies are ****ing me over!"
 
Back
Top Bottom